Evolution AB/ SE0012673267 /
2024-07-26 5:30:00 PM | Chg. +13.50 | Volume | Bid5:30:00 PM | Ask5:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1,033.00SEK | +1.32% | 174,577 Turnover: 60.72 mill. |
-Bid Size: - | -Ask Size: - | 222.72 bill.SEK | - | - |
GlobeNewswire
06-24
4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire
06-21
Revolutionizing Gaming: Secret Casino Tips Release New Article on The Cutting-Edge Technologies Behi...
GlobeNewswire
06-20
Welsbach Technology Metals Acquisition Corp. Announces Extension Proposal and Non-Redemption Agreeme...
GlobeNewswire
06-19
OSE Immunotherapeutics Reports on its 2024 General Shareholders’ Meeting and the Evolution of the B...
GlobeNewswire
06-18
Sterling Digital Print Adds Second Canon varioPRINT iX Sheetfed Inkjet Press Just Months After First...
GlobeNewswire
06-18
Atsign Announces Evolution of Secure Remote Access Solution: Introducing NoPorts
GlobeNewswire
06-18
4DMT to Present Initial Interim 24-week Landmark Analysis from the 4D-150 Phase 2 PRISM Population E...
GlobeNewswire
06-13
Lantronix Wins 2024 IoT Evolution Asset Tracking Award for FOX3 Telematic Gateway
GlobeNewswire
06-08
4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion C...
GlobeNewswire
06-06
4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Mo...
GlobeNewswire
05-31
Invivyd Announces General Alignment with U.S. FDA on a Repeatable, Expedient Emergency Use Authoriza...
GlobeNewswire
05-30
4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibro...
Newsfile Corp
05-30
Eywa, Dubai by R.Evolution, Wins the Title of World's Best Property, 2023-24, and Best International...
GlobeNewswire
05-22
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-...